Bionano Genomics, Inc. (BNGO)
$1.36+0.74%Close
SELLCRISIS · day 10
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $16M
- Beta
- 1.66
- P/E (TTM)
- -0.36
- Short % float
- 18.87%
- Days to cover
- 2.1
- SI change
- +77.9%
- 1W
- -6.21%
- 1M
- +2.26%
- vs SPY 1W
- -6.07%
- vs SPY 1M
- -0.25%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 6
- VALUE
- 10
- GROWTH
- 34
- GARP
- 5
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-47.3%
REV YoY-
ROE-78.8%
EPS YoY-
ROA-67.6%
GROSS48
OP-107
NET-107
[VALUATION]
P/E TTM-0.36
P/E FWD-
SECTOR PE20.34
INDUSTRY PE45.85
P/B0.50
P/FCF-
EV/EBITDA-0.83
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E21.21
ALTMAN Z-
CURR RATIO2.48
ND/EBITDA-
BETA1.66
Company news
FAQ
- What is LOPJLB’s current signal on BNGO?
- LOPJLB’s latest quantitative signal on Bionano Genomics, Inc. (BNGO) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is BNGO in?
- Bionano Genomics, Inc. (BNGO) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Bionano Genomics, Inc. (BNGO) do?
- Bionano Genomics, Inc. focuses on providing advanced solutions for analyzing genomes. The company's flagship offering is Saphyr, a complete system that processes samples to results, enabling the analysis of structural variations in the genome using optical genome mapping. This technology is vital for deciphering genetic variations and their functional roles. The Saphyr platform includes the Sap…